RP
RMD icon

Regal Partners’s ResMed RMD Stock Holding History

Regal Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,800
Closed -$434K – 129
2025
Q4 		$434K Buy
1,800
+500
+38% +$128K 0.03% 89
2025
Q3 		$356K Sell
1,300
-1,000
-43% -$273K 0.03% 70
2025
Q2 		$593K Buy
+2,300
New +$549K 0.05% 43
2023
Q3 		– Sell
-23,600
Closed -$5.16M – 44
2023
Q2 		$5.16M Buy
23,600
+9,600
+69% +$2.14M 1.12% 16
2023
Q1 		$3.07M Buy
+14,000
New +$3.04M 0.6% 23
2022
Q4 		– Sell
-22,707
Closed -$4.96M – 44
2022
Q3 		$4.96M Buy
22,707
+2,707
+14% +$616K 1.04% 17
2022
Q2 		$4.19M Buy
+20,000
New +$4.26M 0.71% 20

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Regal Partners's RMD Position: Q1 2026 in Review

Regal Partners sold out of ResMed (RMD) in Q1 2026, closing a stake of 1,800 shares — an estimated $434K sold.

Regal Partners first reported a position in RMD in Q2 2022 and held it in 7 quarters. The position peaked at $5.16M in Q2 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Regal Partners reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Regal Partners sold 1,800 ResMed shares in Q1 2026, an estimated $434K.
  • Regal Partners first reported a position in ResMed in Q2 2022 and held it in 7 quarters.
  • Regal Partners's ResMed position peaked at $5.16M in Q2 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Regal Partners's 13F filing for Q1 2026, filed 15 May 2026.